Pharmaceutical Intermediate Purification via Continuous Distillation
Engineering Case Study
Scenario
Project Type: New continuous purification train for chiral API intermediate (methyl ester of L-phenylglycine) in GMP-compliant facility. Location Context: Swiss manufacturing site with strict environmental controls (solvent emissions <1 ppm VOC); requires solvent recovery (>99.2% recovery target) and zero batch-to-batch variability. Constraints: Feed contains 120 ppm heavy impurity (dimer); column must operate below 65°C to prevent racemization; stainless steel 316L only; no open steam allowed (risk of hydrolysis); feed is pre-heated liquid (q = 0.98).
Given Data
- Relative Volatility (α) = 3.20 (ester/water at 55°C, vacuum: 120 mbar)
- Equilibrium Constant (K) = 3.15 (measured via GC headspace analysis on pilot column)
- Feed Composition (x_F) = 0.78 mol fraction ester
- Distillate Purity (x_D) = 0.992 mol fraction ester
- Bottoms Purity (x_B) = 0.004 mol fraction ester (to reject dimer and water)
Calculation
- Feed thermal condition q = 0.98 → use modified Underwood formulation accounting for q-line intersection.
- Software computes θ iteratively between x_B and x_D, yielding θ = 2.418.
- Underwood’s second equation adjusted for q ≠ 1: $$R_m = \frac{x_D}{x_D - \theta} \left(1 - \frac{\theta}{\alpha}\right) \left[1 + \frac{q(\theta - 1)}{x_F - \theta}\right] - 1$$ Substituting values: Rₘ = (0.992/(0.992−2.418)) × (1−2.418/3.20) × [1 + (0.98×(2.418−1))/(0.78−2.418)] − 1 ≈ 1.421.
- Tool output: Rₘ = 1.421, reported as 1.42.
Result and Decision
With Rₘ = 1.42, a design reflux ratio of R = 1.85 (1.3× safety factor) was selected—well within pump and condenser capacity. The resulting 28-tray structured packing column (1.1 m diameter, Sulzer BX) met all purity targets in qualification runs and reduced solvent inventory by 40% vs. prior batch process. Real-time NIR monitoring confirmed x_D stability ±0.003 mol fraction over 120 h.
Lesson
When feed is not saturated liquid (q ≠ 1), neglecting q-correction underestimates Rₘ by up to 15% — always input measured q or enthalpy data; for pharmaceutical applications, even small Rₘ errors risk failing ICH Q5A impurity thresholds.